467 related articles for article (PubMed ID: 16481874)
1. Cardiovascular disease in the dialysis population: prognostic significance of arterial disorders.
Guérin AP; Pannier B; Marchais SJ; London GM
Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):105-10. PubMed ID: 16481874
[TBL] [Abstract][Full Text] [Related]
2. Higher brachial-ankle pulse wave velocity is associated with more advanced carotid atherosclerosis in end-stage renal disease.
Munakata M; Sakuraba J; Tayama J; Furuta T; Yusa A; Nunokawa T; Yoshinaga K; Toyota T
Hypertens Res; 2005 Jan; 28(1):9-14. PubMed ID: 15969249
[TBL] [Abstract][Full Text] [Related]
3. Arterial wave reflections and mortality in haemodialysis patients--only relevant in elderly, cardiovascularly compromised?
Covic A; Mardare N; Gusbeth-Tatomir P; Prisada O; Sascau R; Goldsmith DJ
Nephrol Dial Transplant; 2006 Oct; 21(10):2859-66. PubMed ID: 16854850
[TBL] [Abstract][Full Text] [Related]
4. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis.
Hermans MM; Brandenburg V; Ketteler M; Kooman JP; van der Sande FM; Gladziwa U; Rensma PL; Bartelet K; Konings CJ; Hoeks AP; Floege J; Leunissen KM
Nephrol Dial Transplant; 2006 May; 21(5):1293-9. PubMed ID: 16396973
[TBL] [Abstract][Full Text] [Related]
5. The challenge of cardiovascular risk factors in end-stage renal disease.
Covic A; Gusbeth-Tatomir P; Goldsmith DJ
J Nephrol; 2003; 16(4):476-86. PubMed ID: 14696749
[TBL] [Abstract][Full Text] [Related]
6. [Cardiovascular system in patients in different stages of chronic kidney disease].
Strózecki P; Kozłowski M; Grajewska M; Kurowski R; Stefańska A; Odrowaź-Sypniewska G; Serafin Z; Lasek W; Nartowicz E; Kubica J; Manitius J
Pol Merkur Lekarski; 2006 Aug; 21(122):125-9; discussion 130-1. PubMed ID: 17144094
[TBL] [Abstract][Full Text] [Related]
7. Pulse wave velocity--a useful tool for cardiovascular surveillance in pre-dialysis patients.
Lemos MM; Jancikic AD; Sanches FM; Christofalo DM; Ajzen SA; Miname MH; Santos RD; Fachini FC; Carvalho AB; Draibe SA; Canziani ME
Nephrol Dial Transplant; 2007 Dec; 22(12):3527-32. PubMed ID: 17704115
[TBL] [Abstract][Full Text] [Related]
8. Influence of chronic renal insufficiency on left ventricular diastolic function in hypertensives without left ventricular hypertrophy.
Nardi E; Cottone S; Mulè G; Palermo A; Cusimano P; Cerasola G
J Nephrol; 2007; 20(3):320-8. PubMed ID: 17557265
[TBL] [Abstract][Full Text] [Related]
9. [Recent advances in the prevention of cardiovascular morbidity and mortality in end-stage renal disease: role of anemia, hyperparathyroidism and calcifications].
Del Vecchio L; Pozzoni P; Limardo M; Caruso S; Fortunato M; Pontoriero G; Locatelli F
G Ital Nefrol; 2007; 24 Suppl 38():25-32. PubMed ID: 17922444
[TBL] [Abstract][Full Text] [Related]
10. Relationship between fetuin-A concentration, elevated levels of inflammatory markers, and arterial wall stiffness in end-stage kidney disease.
Kuźniar J; Porazko T; Klinger M
J Ren Nutr; 2008 Jan; 18(1):83-6. PubMed ID: 18089450
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection as a risk factor for increased aortic stiffness and cardiovascular events in dialysis patients.
Oyake N; Shimada T; Murakami Y; Ishibashi Y; Satoh H; Suzuki K; Matsumory A; Oda T
J Nephrol; 2008; 21(3):345-53. PubMed ID: 18587722
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of cardiovascular disease in chronic renal disease.
Foley RN; Parfrey PS; Sarnak MJ
J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
[TBL] [Abstract][Full Text] [Related]
13. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients.
Adragao T; Pires A; Lucas C; Birne R; Magalhaes L; Gonçalves M; Negrao AP
Nephrol Dial Transplant; 2004 Jun; 19(6):1480-8. PubMed ID: 15034154
[TBL] [Abstract][Full Text] [Related]
14. Markers of arterial stiffness are risk factors for progression to end-stage renal disease among patients with chronic kidney disease stages 4 and 5.
Taal MW; Sigrist MK; Fakis A; Fluck RJ; McIntyre CW
Nephron Clin Pract; 2007; 107(4):c177-81. PubMed ID: 17975325
[TBL] [Abstract][Full Text] [Related]
15. Hypertension in dialysis: pathophysiology and treatment.
D'Amico M; Locatelli F
J Nephrol; 2002; 15(4):438-45. PubMed ID: 12243377
[TBL] [Abstract][Full Text] [Related]
16. Heart rate as independent prognostic factor for mortality in normotensive hemodialysed patients.
Cice G; Di Benedetto A; D'Andrea A; D'Isa S; De Gregorio P; Marcelli D; Gatti E; Calabrò R
J Nephrol; 2008; 21(5):704-12. PubMed ID: 18949725
[TBL] [Abstract][Full Text] [Related]
17. Magnesium in chronic kidney disease: challenges and opportunities.
Kanbay M; Goldsmith D; Uyar ME; Turgut F; Covic A
Blood Purif; 2010; 29(3):280-92. PubMed ID: 20090315
[TBL] [Abstract][Full Text] [Related]
18. [Characteristics of hyperhomocysteinemia in dialysis patients].
Lovcić V; Kes P; Reiner Z
Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
[TBL] [Abstract][Full Text] [Related]
19. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
[TBL] [Abstract][Full Text] [Related]
20. [Major impact of arteriosclerosis on cardiovascular morbidity and mortality].
Gusbeth-Tatomir P; Covic A
Rev Med Chir Soc Med Nat Iasi; 2005; 109(1):11-5. PubMed ID: 16607820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
